Erratum: Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma (Korean J Intern Med, (2021) 36, (1001-1013), 10.3904/kjim.2020.549)

Jae Woo Jung, Hae Sim Park, Choon Sik Park, Sang Heon Cho, Inseon S. Choi, Hee Bom Moon, Soon Seog Kwon, Ho Joo Yoon, Jung Won Park, Jong Myung Lee, Dong Chull Choi, Byoung Whui Choi

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the article cited above, there was an error in Figure 3B. A corrected version of Figure 3B is attached. (Figure Presented). We apologize for any inconvenience that this may have caused.

Original languageEnglish
Pages (from-to)1260
Number of pages1
JournalKorean Journal of Internal Medicine
Volume36
Issue number5
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 The Korean Association of Internal Medicine.

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Erratum: Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma (Korean J Intern Med, (2021) 36, (1001-1013), 10.3904/kjim.2020.549)'. Together they form a unique fingerprint.

Cite this